Prof. Dr. Katharine Barnard-Kelly will give a lecture entitled “Delivering The Quintuple Goal of Healthcare Through Spotlight-AQ Digital Health”.
About the Speaker:
Dr. Katharine Barnard-Kelly is an internationally recognised expert in the fields of the psychosocial impact of diabetes and other chronic conditions, and their management. She led the only team to receive FDA Medical Device Development Tool (MDDT) qualification for a diabetes patient-reported outcome measure (INSPIRE). She also founded and chaired the FDA’s RESCUE Collaborative Community and led the group responsible for the consensus statement on the standardisation of patient-reported outcomes in people with diabetes. She has authored more than 250 scientific publications and has played a pivotal role in fostering effective communication between patients and healthcare professionals.
When/Where: 11th november 2026, 10h30, at Ispa – Instituto Universitário (Sala de Atos).
Abstract:
Conventional cost-utility analysis is essential for health technology assessment, but it may underestimate the value of digital diabetes interventions that transform care delivery.
Spotlight-AQ is a pre-visit biopsychosocial assessment and clinical workflow support tool designed to make diabetes consultations more personalised, focused and action-oriented.
We explore an economic model that incorporates the monetisation of time saved during consultations, reductions in healthcare professional burnout, and device integration, using Medicaid budget impact estimates. The findings are particularly promising.
